Nuvectis Pharma, Inc. — Form D

Nuvectis Pharma, Inc. of FORT LEE, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2022-08-10. The offering totals $15.9M, of which $15.9M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2022-08-10
• Form: D
• Accession: 0001104659-22-088650
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $15.9M
• Amount sold: $15.9M
• Investors: 19
• Date of first sale: 2022-07-27
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-455560

Issuer

• Name: Nuvectis Pharma, Inc.
• CIK: 0001875558
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2020
• Address: 1 BRIDGE PLAZA, FORT LEE, NJ, 07024
• Phone: (201) 614-3150

Officers, directors & promoters (8)

More

• CIK 1875558 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search